References
- MatthayKKMarisJMSchleiermacherGNeuroblastomaNat Rev Dis Primers201621607827830764
- CapassoMDiskinSJGenetics and genomics of neuroblastomaCancer Treat Res2010155658420517688
- IrwinMSParkJRNeuroblastoma: paradigm for precision medicinePediatr Clin North Am201562122525625435121
- ParkJRBagatellRCohnSLRevisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning MeetingJ Clin Oncol201735222580258728471719
- EspositoMRAveicSSeydelAToniniGPNeuroblastoma treatment in the post-genomic eraJ Biomed Sci20172411428178969
- MarisJMRecent advances in neuroblastomaN Engl J Med2010362232202221120558371
- CheungNKDyerMANeuroblastoma: developmental biology, cancer genomics and immunotherapyNat Rev Cancer201313639741123702928
- SchwabMWestermannFHeroBBertholdFNeuroblastoma: biology and molecular and chromosomal pathologyLancet Oncol20034847248012901961
- MarisJMHogartyMDBagatellRCohnSLNeuroblastomaLancet200736995792106212017586306
- DuBoisSGKalikaYLukensJNMetastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survivalJ Pediatr Hematol Oncol199921318118910363850
- CookMNOlshanAFGuessHAMaternal medication use and neuroblastoma in offspringAm J Epidemiol2004159872173115051581
- MenegauxFOlshanAFNegliaJPPollockBHBondyMLDay care, childhood infections, and risk of neuroblastomaAm J Epidemiol2004159984385115105177
- MosseYPLaudenslagerMKhaziDGermline PHOX2B mutation in hereditary neuroblastomaAm J Hum Genet200475472773015338462
- BourdeautFTrochetDJanoueix-LeroseyIGermline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastomaCancer Lett20052281–2515815949893
- ChenYTakitaJChoiYLOncogenic mutations of ALK kinase in neuroblastomaNature2008455721597197418923524
- MosseYPLaudenslagerMLongoLIdentification of ALK as a major familial neuroblastoma predisposition geneNature2008455721593093518724359
- TolbertVPCogginsGEMarisJMGenetic susceptibility to neuroblastomaCurr Opin Genet Dev201742819028458126
- HeJZouYWangTGenetic variations of GWAS-identified genes and neuroblastoma susceptibility: a replication study in Southern Chinese childrenTransl Oncol201710693694129024823
- SchwabMAlitaloKKlempnauerKHAmplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumourNature198330559312452486888561
- KramerMRibeiroDArsenian-HenrikssonMDellerTRohrerHProliferation and survival of embryonic sympathetic neuroblasts by MYCN and activated ALK signalingJ Neurosci20163640104251043927707976
- GuglielmiLCinnellaCNardellaMMYCN gene expression is required for the onset of the differentiation programme in neuroblastoma cellsCell Death Dis20145e108124556696
- WestermarkUKWilhelmMFrenzelAHenrikssonMAThe MYCN oncogene and differentiation in neuroblastomaSemin Cancer Biol201121425626621849159
- PetroniMVeschiVProdosmoAMYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage responseMol Cancer Res201191677721173028
- BeckersAVan PeerGCarterDRMYCN-driven regulatory mechanisms controlling LIN28B in neuroblastomaCancer Lett2015366112313226123663
- StermannAHuebenerNSeidelDTargeting of MYCN by means of DNA vaccination is effective against neuroblastoma in miceCancer Immunol Immunother201564101215122726076666
- WilliamsRDChagtaiTAlcaide-GermanMMultiple mechanisms of MYCN dysregulation in Wilms tumourOncotarget2015697232724325749049
- ThompsonDVoKTLondonWBIdentification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: a report from the International Neuroblastoma Risk Group projectCancer2016122693594526709890
- BrodeurGMSeegerRCSchwabMVarmusHEBishopJMAmplification of N-myc in untreated human neuroblastomas correlates with advanced disease stageScience19842244653112111246719137
- SeegerRCBrodeurGMSatherHAssociation of multiple copies of the N-myc oncogene with rapid progression of neuroblastomasN Engl J Med198531318111111164047115
- HeJZouYLiuXAssociation of common genetic variants in pre-microRNAs and neuroblastoma susceptibility: a two-center study in Chinese childrenMol Ther Nucleic Acids2018111829858046
- ZhangZChangYJiaWLINC00673 rs11655237 C>T confers neuroblastoma susceptibility in Chinese populationBiosci Rep2018381BSR2017166729339420
- ZhuoZJLiuWZhangJFunctional polymorphisms at ERCC1/XPF genes confer neuroblastoma risk in Chinese childrenEBioMedicine20183011311929544698
- HeJZhongWZengJLMO1 gene polymorphisms contribute to decreased neuroblastoma susceptibility in a Southern Chinese populationOncotarget2016716227702277827009839
- HeJWangFZhuJThe TP53 gene rs1042522 C>G polymorphism and neuroblastoma risk in Chinese childrenAging (Albany NY)20179385285928275206
- HeJWangFZhuJAssociation of potentially functional variants in the XPG gene with neuroblastoma risk in a Chinese populationJ Cell Mol Med20162081481149027019310
- GongJTianJLouJA polymorphic MYC response element in KBTBD11 influences colorectal cancer risk, especially in interaction with a MYC regulated SNP rs6983267Ann Oncol2017293632639
- LiJZouLZhouYA low-frequency variant in SMAD7 modulates TGF-beta signaling and confers risk for colorectal cancer in Chinese populationMol Carcinog20175671798180728218435
- LouJGongJKeJA functional polymorphism located at transcription factor binding sites, rs6695837 near LAMC1 gene, confers risk of colorectal cancer in Chinese populationsCarcinogenesis201738217718328039327
- ZouDLouJKeJIntegrative expression quantitative trait locus-based analysis of colorectal cancer identified a functional polymorphism regulating SLC22A5 expressionEur J Cancer2018931929428571
- ZimmermanKAYancopoulosGDCollumRGDifferential expression of myc family genes during murine developmentNature198631960567807832419762
- GradyEFSchwabMRosenauWExpression of N-myc and c-src during the development of fetal human brainCancer Res19874711293129363552210
- van GolenCMSoulesMEGraumanARFeldmanELN-Myc overexpression leads to decreased beta1 integrin expression and increased apoptosis in human neuroblastoma cellsOncogene200322172664267312730680
- TanakaNFukuzawaMMYCN downregulates integrin α1 to promote invasion of human neuroblastoma cellsInt J Oncol200833481582118813796
- SongLAraTWuHWOncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastomaJ Clin Invest200711792702271217710228
- BrandettiEVenezianiIMelaiuOMYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastomaOncoimmunology201766e131643928680748
- DahlinAMHollegaardMVWibomCCCND2, CTNNB1, DDX3X, GLI2, SMARCA4, MYC, MYCN, PTCH1, TP53, and MLL2 gene variants and risk of childhood medulloblastomaJ Neurooncol20151251757826290144